Secondary prevention: indefinite vs discontinued antithrombotic therapy. ∗Trials using DOAC. Risk of bias legend: A, random sequence generation (selection bias); B, allocation concealment (selection bias); C, blinding of participants and personnel (performance bias); D, blinding of outcome assessment (detection bias); E, incomplete outcome data (attrition bias); F, selective reporting (reporting bias); G, other bias.